pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Phase 2
rF1V Vaccine
Plague
U.S. Army Medical Research Institute of Infectious Diseases
Marketed
rabeprazole DR
Rabeprazole Sodium (rabeprazole [INN])
Acid Indigestion (Heartburn/Pyrosis)
Torrent Pharma Inc
Marketed
rabeprazole sodium DR
Aciphex (rabeprazole sodium)
Acid Indigestion (Heartburn/Pyrosis)
Eisai Co Ltd
Marketed
← prev
page 249 of 271
next →
Pain
89
Neurology
1
rabies [strain Wistar PM/WI 38-1503-3M] vaccine
Imovax
Rabies
Sanofi Pasteur Inc
Marketed
rabies immune globulin (human)
KedRAB (rabies immune globulin (human))
Rabies
Kedrion Biopharma Inc
Phase 2
racemic ketamine
ketamine [INN]
Complex Regional Pain Syndrome (Sympathetic Reflex Dystro…
PharmaTher Holdings Ltd
Phase 2
rademikibart
rademikibart [INN]
Acute Asthma
Suzhou Connect Biopharmaceuticals Ltd
Phase 2
radgocitabine
radgocitabine [INN]
Refractory Acute Myeloid Leukemia
Delta-Fly Pharma Inc
Phase 3
radiprodil
radiprodil
Unspecified Neurologic Disorders
GRIN Therapeutics Inc
Marketed
radium Ra 223 dichloride
Xofigo (radium Ra 223 dichloride)
Bone Metastasis
Bayer HealthCare Pharmaceuticals Inc
Phase 3
rafutrombopag
rafutrombopag [INN]
Thrombocytopenia
Jiangsu Hengrui Pharmaceuticals Co Ltd
Phase 1
ragistomig
ragistomig [INN]
Esophageal Cancer
$NBP
NovaBridge Biosciences
Phase 2
raguneprocel
raguneprocel [INN]
Parkinson's Disease
Sumitomo Chemical Co Ltd
Phase 3
ralinepag XR
ralinepag
Pulmonary Arterial Hypertension
$UTHR
UNITED THERAPEUTICS Corp
Marketed
raloxifene hydrochloride
Raloxifene Hydrochloride
Post Menopausal Osteoporosis
Modavar Pharmaceuticals LLC
Marketed
raltegravir potassium
Raltegravir (raltegravir potassium)
Human Immunodeficiency Virus (HIV) Infections (AIDS)
Lupin Ltd
Marketed
ramipril
Ramipril
Cardiovascular Risk Factors
CorePharma LLC
Phase 3
ramucirumab
Cyramza (ramucirumab)
Adenocarcinoma Of The Gastroesophageal Junction
Eli Lilly and Co
Marketed
ranibizumab
Lucentis (ranibizumab)
Choroidal Neovascularization
Genentech Inc
Marketed
ranibizumab SR
Susvimo (ranibizumab)
Diabetic Macular Edema
Genentech Inc
Marketed
ranitidine hydrochloride
Ranitidine Hydrochloride
Systemic Mastocytosis
VKT Pharma Pvt Ltd
Marketed
ranolazine ER
Ranolazine
Chronic Stable Angina
Laurus Generics Inc
Phase 2
ranpirnase
Onconase (ranpirnase)
Genital Warts (Condylomata Acuminata)
Okogen Inc
Phase 1
rapaprutug
rapaprutug [INN]
Pulmonary Arterial Hypertension
Zymedi
Marketed
rasagiline
Rasagiline
Parkinson's Disease
Heritage Pharmaceuticals Inc
Marketed
rasagiline mesylate
Rasagiline Mesylate
Parkinson's Disease
Carnegie Pharmaceuticals LLC
Marketed
rasburicase
Elitek (rasburicase)
Hyperuricemia
Sanofi-Aventis US LLC
Phase 1
ratangratinib
ratangratinib [INN]
Bile Duct Cancer (Cholangiocarcinoma)
3D Medicines Inc
Marketed
ravulizumab LA
Ultomiris (ravulizumab)
Delayed Graft Function (DGF)
Alexion Pharmaceuticals Inc
Marketed
raxibacumab
Raxibacumab
Anthrax
$EBS
Emergent BioSolutions Inc.
